Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
Atkins MB, Abu-Sbeih H, Ascierto PA, Bishop MR, Chen DS, Dhodapkar M, Emens LA, Ernstoff MS, Ferris RL, Greten TF, Gulley JL, Herbst RS, Humphrey RW, Larkin J, Margolin KA, Mazzarella L, Ramalingam SS, Regan MM, Rini BI, Sznol M.
Atkins MB, et al. Among authors: mazzarella l.
J Immunother Cancer. 2022 Sep;10(9):e005413. doi: 10.1136/jitc-2022-005413.
J Immunother Cancer. 2022.
PMID: 36175037
Free PMC article.